These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19652540)

  • 21. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
    Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
    Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
    Chen D; Yoon JB; Gu W
    Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiation.
    Aguda BD; Kim Y; Kim HS; Friedman A; Fine HA
    Biophys J; 2011 Nov; 101(9):2082-91. PubMed ID: 22067145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
    Gjerset RA
    J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
    Kuo ML; den Besten W; Thomas MC; Sherr CJ
    Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human ARF binds E2F1 and inhibits its transcriptional activity.
    Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
    Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
    Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
    Bertwistle D; Sugimoto M; Sherr CJ
    Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARF differentially modulates apoptosis induced by E2F1 and Myc.
    Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
    Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.
    Chen D; Kon N; Zhong J; Zhang P; Yu L; Gu W
    Mol Cell; 2013 Jul; 51(1):46-56. PubMed ID: 23747016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.
    Lee S; Cho YE; Kim SH; Kim YJ; Park JH
    Oncotarget; 2017 Mar; 8(10):16293-16302. PubMed ID: 27323397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDM2-ARF complex regulates p53 sumoylation.
    Chen L; Chen J
    Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleophosmin blocks mitochondrial localization of p53 and apoptosis.
    Dhar SK; St Clair DK
    J Biol Chem; 2009 Jun; 284(24):16409-16418. PubMed ID: 19366707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
    Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
    Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.
    Tago K; Funakoshi-Tago M; Itoh H; Furukawa Y; Kikuchi J; Kato T; Suzuki K; Yanagisawa K
    Oncogene; 2015 Jan; 34(3):314-22. PubMed ID: 24469041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity.
    Zhang Q; Spears E; Boone DN; Li Z; Gregory MA; Hann SR
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):978-83. PubMed ID: 23277542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.
    Valsesia-Wittmann S; Magdeleine M; Dupasquier S; Garin E; Jallas AC; Combaret V; Krause A; Leissner P; Puisieux A
    Cancer Cell; 2004 Dec; 6(6):625-30. PubMed ID: 15607966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
    Bertwistle D; Sherr CJ
    Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.